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Abstract
Background: Polytobacco product use is suspected to be common, dynamic across time, and 
increase risk for adverse behavioral outcomes. We statistically modeled characteristic types of 
polytobacco use trajectories during mid-adolescence and tested their prospective association with 
substance use and mental health problems.
Methods: Adolescents (N = 3393) in Los Angeles, CA, were surveyed semiannually from 9th to 11th 
grade. Past 6-month combustible cigarette, e-cigarette, or hookah use (yes/no) over four assess-
ments were analyzed using parallel growth mixture modeling to identify a parsimonious set of 
polytobacco use trajectories. A  tobacco product use trajectory group was used to predict sub-
stance use and mental health at the fifth assessment.
Results: Three profiles were identified: (1) tobacco nonusers (N = 2291, 67.5%) with the lowest use 
prevalence (<3%) of all products across all timepoints; (2) polyproduct users (N = 920, 27.1%) with 
moderate use prevalence of each product (8–35%) that escalated for combustible cigarettes but 
decreased for e-cigarettes and hookah across time; and (3) chronic polyproduct users (N = 182, 
5.4%) with high prevalence of each product use (38–86%) that escalated for combustible cigarettes 
and e-cigarettes. Nonusers, polyproduct users, and chronic polyproduct users reported succes-
sively higher alcohol, marijuana, and illicit drug use and ADHD at the final follow-up, respectively. 
Both tobacco using groups (vs. nonusers) reported greater odds of depression and anxiety at the 
final follow-up but did not differ from each other.
Conclusions: Adolescent polytobacco use may involve a common moderate risk trajectory and 
a less common high-risk chronic trajectory. Both trajectories predict substance use and mental 
health symptomology.
Implications: Variation in use and co-use of combustible cigarette, e-cigarette, and hookah use in 
mid-adolescence can be parsimoniously characterized by a small set common trajectory profiles 
in which polyproduct use are predominant patterns of tobacco product use, which predict adverse 
behavioral outcomes. Prevention and policy addressing polytobacco use (relative to single product 
use) may be optimal tobacco control strategies for youth, which may in turn prevent other forms of 
substance use and mental health problems.
Introduction
Combustible cigarette smoking among high school students has 
declined to its lowest level since 1991,1 however use of alternative 
tobacco products, such as electronic cigarette (e-cigarette) and hoo-
kah (tobacco water pipe) has increased in recent years.2,3 The wide-
spread availability of conventional and alternative tobacco products 
has resulted in numerous, dynamic patterns of polytobacco prod-
uct use (ie, use of three or more tobacco products) among youth.4–7 
In 2015, 13.0% of high school students used two or more tobacco 
products in the past 30 days,4 and 64.6% of past 30-day e-cigarette 
users and 83.9% of past 30-day cigarette users, respectively, were 
polytobacco users.8
The numerous configurations of polyproduct use patterns pose 
a challenge to tobacco control efforts, as it is unclear which forms 
of polyproduct use should garner the highest priority. Identifying a 
more parsimonious set of common, homogenous tobacco use pat-
terns can identify particular forms of poly use that can be targeted 
in prevention programs, policies, and surveillance. The small body 
of evidence to date suggests that there are distinct groups of adoles-
cents who temporarily experiment with multiple tobacco products 
as well as others who may use one or more products across multiple 
time points.9–11 Previous research investigating youth tobacco prod-
uct use trajectories has typically focused on a single tobacco product 
at a time,12 and there is little longitudinal research assessing complex 
developmental patterns of polytobacco use throughout adolescence. 
Person-centered statistical approaches, such as parallel process latent 
growth mixture modeling (GMM), which parsimoniously account 
for heterogeneity in the use and co-use patterns of multiple tobacco 
products over time, are needed to identify homogeneous subgroups 
of adolescents with similar longitudinal patterns of change in use 
and co-use of multiple tobacco products across adolescence.13
Identifying prototypical patterns of polytobacco use across ado-
lescence is also important for understanding which configurations 
of polytobacco use patterns may be associated with adverse health 
outcomes. Tobacco product use among high school students has 
been shown to be associated with the use of alcohol and other illicit 
substances,14 with the level or prevalence of substance use increasing 
proportionally with the number of tobacco products used.15 Recent 
cross-sectional data suggests that polytobacco use is associated with 
increased likelihood of alcohol and marijuana use16–18 and mental 
health symptomology (ie, depression and anxiety).19 Additionally, 
prospective data indicates that more frequent e-cigarette and com-
bustible cigarette use may also be associated with increased sever-
ity of depressive symptomology.20,21 However, it is unknown if 
specific polytobacco use trajectories are longitudinally associated 
with increases in substance use and mental health problems during 
mid-adolescence.
In this longitudinal study of Los Angeles area high school stu-
dents, we examined heterogeneity in developmental patterns of poly-
tobacco use across ages 14 to 16  years and identify profiles with 
distinct trajectories of use and co-use of the three tobacco products 
that are currently most popular among adolescents (ie, combustible 
cigarette, e-cigarette, and hookah).3 We also examine prospective 
associations of polytobacco use trajectories with substance use (ie, 
alcohol, marijuana, and illicit drugs) and mental health problems 
(ie, depression, anxiety, and attention deficit/hyperactivity disorder 
[ADHD]). Such data can inform product-specific targets for tobacco 
prevention interventions among youth who experiment with and 
regularly use popular tobacco products, and may also elucidate poly-
tobacco use trajectories that confer risk for subsequent substance use 
and mental health problems.
Methods
Sample and Procedure
Data were drawn from the Happiness & Health Study, a longitu-
dinal cohort survey of substance use and mental health among high 
school students in the Los Angeles metropolitan area.22 Forty public 
high schools were approached to participate in the study due to their 
demographic characteristics, proximity, and willingness to partici-
pate in research; 10 schools agreed to participate in the study (see 
Supplementary Table S1 for characteristics of participating schools 
in reference to Los Angeles county public schools).
Of the 4100 eligible 9th grade students, 3396 students and 
their parents provided active written or verbal assent and con-
sent, respectively, to enroll in the study. Data collection involved 
five semiannual assessments: baseline (fall 9th grade, 2013; N 
(surveyed)  =  3383, 99.6%), 6-month (spring 9th grade, 2014; 
N = 3292, 96.9%), 12-month (fall 10th grade, 2014; N = 3281, 
96.6%), 18-month (spring 10th grade, 2015; N = 3251, 95.7%), 
and 24-month (fall 11th grade, 2015; N = 3232, 95.2%) follow-
ups. At each assessment, paper-and-pencil surveys were adminis-
tered onsite in students’ classrooms. Students not in class during 
data collections completed surveys by telephone, Internet, or mail 
(6-month follow-up: N  =  49, 12-month follow-up: N  =  142, 
18-month follow-up: N = 216, 24-month follow-up: N = 247). The 
University of Southern California Health Sciences Review Board 
approved this study.
Measures
Tobacco Product Use
At each assessment, items based on the Youth Behavior Risk 
Surveillance (YRBS)23 and Monitoring the Future (MTF)3 surveys 
assessed the past 6-month use of combustible cigarettes (described 
as even a few-puffs), e-cigarettes, and hookah. Use of each tobacco 
product was dichotomously coded as 0 (No) and 1 (Yes) to indicate 
the prevalence of past 6-month use of each product.
Substance Use Outcomes
At the baseline and 24-month assessments, past 30-day use of alco-
hol (“one full drink of alcohol and not just a few sips for religious 
purposes”), marijuana, and other illicit drugs (eg, illicit and pre-
scription stimulants, prescription painkillers) were measured using 
well-validated items assessing the number of days used each sub-
stance was used in the past 30 days (forced choice with 9 ordinal 
options ranging from 1 [0 days] to 9 [all 30 days]).23 These response 
categories were recoded into quantitative count variables by taking 
the mean value of each ordinal category: 0 (0 days), 2 (1–2 days), 
4 (3–5 days), 8 (6–9 days), 12 (10–14 days), 17 (15–19 days), 22 
(20–24 days), 27 (25–29 days), and 30 (all 30 days).
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Mental Health Outcomes
At the baseline and 24-month assessments, depressive symptomology 
was assessed with the Center for Epidemiologic Studies Depression 
Scale (CESD).24 The CESD is a 20-item measure of depressive symp-
toms experienced over the past week, rated on a 4-point Likert scale, 
ranging from 0 (Rarely or None of the time; 0–1 days) to 3 (Most 
or all of the time; 5–7 days). The total sum score of the 20 items was 
computed (Cronbach’s αs = .81 and .83 for baseline and 24-month 
follow-up, respectively) and was dichotomized (yes/no) based on the 
measure’s recommended cutoff for clinical depression.25 The Revised 
Children’s Anxiety and Depression Scale (RCADS)26 was used to 
assess respondents’ generalized anxiety. Raw sum scores of six items 
(αs>.89) were converted into gender- and age-normed standardized 
T-scores and were dichotomously coded for the borderline clinical 
cutoff of the Generalized Anxiety Disorder (GAD). The 18-item 
Current Symptoms Scale-Self Report Form measure of DSM-IV 
ADHD27 assessed current ADHD symptoms (αs > .92), with nine 
items measuring the inattention and hyperactivity-impulsivity symp-
tom dimensions of ADHD. Respondents rated how frequently they 
experienced each individual symptom during the past 6  months 
from 0 (never or rarely) to 3 (very often). If 12 or more items were 
endorsed at ratings of 2 or higher, ADHD was dichotomously coded 
above clinical cutoff. Because ADHD measures were not added to 
the assessment battery until the 6-month follow-up assessment, the 
ADHD score at the 6-month follow-up was used as the baseline 
score for this analysis.
Covariates
A priori covariates were selected based on their association with 
tobacco use or mental health outcomes in the extant literature.28,29 
At baseline, time-invariant sociodemographic covariates including 
age, gender, race/ethnicity, and highest parental education level were 
assessed with investigator-defined forced-choice items (see response 
categories in Table 1). Past 6-month use of other tobacco products 
(ie, smokeless tobacco, cigars, cigarillos, dissolvable) at baseline was 
assessed with four items from the YRBS and MTF studies. This other 
tobacco use covariate was dichotomously coded (0 = no use; 1 = any 
use of other forms of tobacco).
Analytic Plan
To characterize trajectories of past 6-month combustible cigarette, 
e-cigarette, and hookah use across the first four assessments, we con-
ducted a series of growth mixture modeling (GMM) analyses—an 
analytic technique that allows for the estimation of subgroups of 
individuals within the population who differ in terms of their ini-
tial levels and rates of change for a specific outcome over time.13 
We utilized a “parallel process” application of GMM, which gener-
ates classes based on covariation across three separate sets of latent 
intercepts and linear slopes (ie, one set of growth factors per tobacco 
product).30 The number of classes that best fit the data for the three 
tobacco use outcomes was selected based on model fit comparisons 
using a series of standard fit indices: Bayesian Information Criterion 
(BIC), sample-size-adjusted BIC (SSA-BIC), Akaike Information 
Criterion (AIC), Lo–Mendell–Rubin (LMR) likelihood ratio test, 
and entropy.31 Optimal models were chosen on the basis of goodness 
of fit and parsimony.
After identifying the polytobacco use trajectory profiles, partici-
pants were assigned to their most probable trajectory class. We then 
utilized regression modeling to test associations of polytobacco use 
trajectory class memberships across baseline to 18-month follow-up 
with substance use and mental health outcomes at the 24-month 
follow-up, with separate models for each outcome. As the substance 
Table 1. Sample Characteristics at Baseline by Polytobacco Use Trajectory Groups
Multiple tobacco product trajectory groups
Total (N = 3393, 
100.0%)
Chronic polyproduct usersd 
(N = 182, 5.4%)
Polyproduct userse 
(N = 920, 27.1%)
Tobacco nonusers 
(N = 2291, 67.5%) p
Sociodemographics/Other tobacco use
Sexa 3393 (100.0) 182 (100.0) 920 (100.0) 2291 (100.0) .15
 Female 1811 (53.4) 95 (52.2) 467 (50.8) 1249 (54.5)
 Male 1582 (46.6) 87 (47.8) 453 (49.2) 1042 (45.5)
Ageb 14.58 (.40) 14.56 (.41)f 14.63 (.41)f 14.55 (.40)f <.001
Race/ethnicitya 3310 (100.0) 173 (100.0) 895 (100.0) 2242 (100.0) <.001
 White 520 (15.7) 29 (16.8) 129 (14.4) 362 (16.1)
 Hispanic 1557 (47.0) 96 (55.5) 492 (55.0) 969 (43.2)
 Black 165 (5.0) 4 (2.3) 44 (4.9) 117 (5.2)
 Asian 535 (16.2) 12 (6.9) 87 (9.7) 436 (19.4)
 Other 533 (16.1) 32 (18.5) 143 (16.0) 358 (16.0)
Parental education levela, c 2491 (100.0) 125 (100.0) 665 (100.0) 1701 (100.0) <.001
 ≤8th grade 76 (3.1) 4 (3.2) 21 (3.2) 51 (3.0)
 Some high school 204 (8.2) 13 (10.4) 77 (11.6) 114 (6.7)
 High school graduate 393 (15.8) 25 (20.0) 125 (18.8) 243 (14.3)
 Some college 491 (19.7) 30 (24.0) 141 (21.2) 320 (18.8)
 College graduate 818 (32.8) 36 (28.8) 201 (30.2) 581 (34.2)
 Graduate degree 509 (20.4) 17 (13.6) 100 (15.0) 392 (23.0)
Other tobacco products usea 3359 (100.0) 179 (100.0) 907 (100.0) 2273 (100.0) <.001
 No use 3243 (96.5) 135 (75.4) 844 (93.1) 2264 (99.6)
 Any use 116 (3.5) 44 (24.6) 63 (6.9) 9 (0.4)
aAvailable (nonmissing) data for respective variable and, for categorical variables, denominator for within-column percentages. n (%). Based on χ2 test of associa-
tion. bMean (SD). Based on the ANOVA test of association. cParticipants who marked “don’t know” response (N = 422) recoded as missing. dEscalating Cigarette 
& e-Cigarette / High Hookah. eEscalating cigarette / Decreasing e-cigarette & hookah. fLSD post hoc analyses results.
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use outcomes (ie, the number of days each substance was used in 
the past 30  days) were zero-inflated and over-dispersed, we uti-
lized negative binomial regression modeling for these outcomes.32 
The negative binomial regression coefficients were exponentiated to 
obtain incidence rate ratios (IRRs). Binary logistic regression mod-
eling was applied for each mental health outcome (dichotomously 
coded above or below clinical cutoff). For all tests, we controlled for 
the aforementioned sociodemographic covariates and each respect-
ive substance use or mental health outcome at baseline.
All analyses were conducted in Mplus33 version 7 with statis-
tical significance set at p < .05. As respondents were clustered within 
schools, a complex analysis was used to adjust parameter standard 
errors for interdependence in the data (ie, the error terms of regres-
sion models were not independent) to avoid an underestimation of 
standard errors. Missing data were managed with full information 
likelihood estimation (FIML).
Results
Preliminary Analyses
Among study enrollees, 3393 students provided at least one data 
point for the tobacco product use outcomes in the primary GMM 
analyses (99.9%), and were included in the analytic sample (see 
Table  1 for Ns of available data). We first examined differences 
in study variables among participants who completed (N  = 3232, 
95.2%) and did not complete (N = 164, 4.8%) the 24-month follow-
up. No significant differences among study variables between these 
two groups were detected (ps  =  .07−.42). As depicted in Table  1, 
the sample was balanced on gender and was sociodemographically 
diverse. The prevalence of past 6-month tobacco use in each assess-
ment is presented in Supplementary Table S2 of the online sup-
plemental materials. Also, the prevalence of substance use and 
mental health symptomology outcomes at baseline is presented in 
Supplementary Table S3 of the online supplemental materials.
Trajectory Groups of Combustible Cigarette, 
E-cigarette, and Hookah Use
Fit indices for parallel GMM analyses (presented in Table 2) con-
verged to suggest the superiority of a three-class solution fitting the 
data best (SSA-BIC = 22 040.438; Entropy = 0.850; LMR p = .014). 
Figure 1 presents the observed trajectories of polytobacco product 
use prevalence across assessments after individuals were assigned to 
each respective group. Approximately 67.5% of adolescents were 
identified as the “Tobacco nonusers” group (N  =  2291). Tobacco 
nonusers reported a negligible prevalence of combustible cigarette, 
e-cigarette, and hookah use in the past 6  months at each assess-
ment (<3%), and their prevalence of use of each tobacco product 
did not significantly change during the study observation period (see 
Figure 1).
The “Polyproduct users” group (N  =  920, 27.1%) displayed 
disparate trajectories of combustible cigarette use and alternative 
tobacco product (ie, e-cigarette, hookah) use. Polyproduct users 
displayed a low prevalence of combustible cigarette use at baseline 
(7.7%), but their prevalence of combustible cigarette use signifi-
cantly increased over follow-up, reaching 19.9% at the 18-month 
follow-up (Slope mean = 0.176, p < .001). However, their prevalence 
of e-cigarette use significantly decreased from 32.5% to 20.8% and 
their prevalence of hookah use significantly decreased from 27.1% 
to 17.2% from baseline to the 18-month follow-up assessment 
(Slope mean = −0.085, p = 0.02 for e-cigarette; Slope mean = −0.157, 
p = 0.01 for hookah).
The “Chronic polyproduct users” group was comprised of 182 
adolescents (5.4%) who displayed the highest prevalence of use 
of each tobacco product at baseline and significantly increased 
their prevalence of combustible cigarette use (Slope mean = 0.355, 
p < .001) and e-cigarette use (Slope mean = 0.389, p < .001) across 
the follow-up period. Their prevalence of combustible cigarette use 
increased from 38.2% at baseline to 67.8% at the 18-month follow-
up, and their prevalence of past 6-month e-cigarette use increased 
from 58.9% at baseline to 83.3%. The prevalence of hookah use in 
Table 2. Fit Indices for Growth Mixture Models
Class # AIC BIC SSA-BIC Entropy LMR p
1 26759.696 26796.473 26777.408 — —
2 22446.874 22526.557 22485.250 0.825 0.0001
3 21981.398 22103.988 22040.438 0.850 0.0144
4 21901.071 22066.567 21980.775 0.816 0.5705
5 21831.845 22040.247 21932.213 0.804 0.5592
AIC = Akaike Information Criterion. BIC = Bayesian Information Criterion. 
SSA-BIC  =  sample-size-adjusted BIC. LMR p  =  The Lo–Mendell–Rubin 
(LMR) likelihood ratio test p value.
Figure  1. Observed trajectories of combustible cigarette, e-cigarette, and hookah use by three groups. N  =  3393. W1  =  Baseline (Mean age  =  14  years). 
W2 = 6-month follow-up. W3 = 12-month follow-up. W4 = 18-month follow-up. The significance of slope mean estimate of each tobacco product use is indicated 
in the legends: *p < 0.05, **p < 0.01. aChronic polyproduct users: Escalating cigarette & e-cigarette / High stable hookah (N = 182, 5.4%). bPolyproduct users: 
Escalating cigarette / Decreasing e-cigarette & hookah (N = 920, 27.1%). cTobacco nonusers (N = 2291, 67.5%).
Nicotine & Tobacco Research, 2018, Vol. 20, Suppl. 1S34
Figure  1. Observed trajectories of combustible cigarette, e-cigarette, and hookah use by three groups. N  =  3393. W1  =  Baseline (Mean age  =  14  years). 
W2 = 6-month follow-up. W3 = 12-month follow-up. W4 = 18-month follow-up. The significance of slope mean estimate of each tobacco product use is indicated 
in the legends: *p < 0.05, **p < 0.01. aChronic polyproduct users: Escalating cigarette & e-cigarette / High stable hookah (N = 182, 5.4%). bPolyproduct users: 
Escalating cigarette / Decreasing e-cigarette & hookah (N = 920, 27.1%). cTobacco nonusers (N = 2291, 67.5%).
this group increased from 45.8% to 60.4% across the follow-ups, 
but the change over time was not significantly different from zero 
(Slope mean = 0.138, p = .19).
Associations of Polytobacco Use Trajectory Groups 
With Substance Use and Mental Health
Table  3 presents the associations of polytobacco use trajectory 
groups with changes in substance use and mental health outcomes 
from baseline to the 24-month follow-up. Compared with Tobacco 
nonusers, Chronic polyproduct users and Polyproduct users used 
alcohol, marijuana, and other illicit drugs a greater number of days 
at the 24-month follow-up after adjusting for respective baseline lev-
els and demographics (ps < .01; Table 3). Also, Chronic polyproduct 
users, compared with Polyproduct users, reported significantly more 
days of alcohol (IRR [95%CI] = 1.90 [1.14, 2.67]; p = .004), mari-
juana (IRR [95%CI] = 2.16 [1.50, 2.82]; p < .001), and other illicit 
drug use (IRR [95%CI] = 2.37 [1.60, 3.14]; p < 0.001) at follow-up. 
In Table 3, we present IRR estimates for each substance use outcome 
and polytobacco use trajectory group contrast.
Chronic polyproduct users and Polyproduct users (vs. Tobacco 
nonusers) were more likely to report depression, anxiety, and ADHD 
symptoms that reached the clinical cutoff at the 24-month follow-up, 
after controlling for sociodemographic factors and baseline mental 
health problems (Table 3). For instance, compared to Tobacco non-
users, the odds of Chronic polyproduct users reporting symptoms 
that reached the clinical cutoff for depression at the final follow-
up were 47% higher (OR [95%CI] = 1.47 [1.15, 1.79]; p < .001). 
Compared with Polyproduct users, Chronic polyproduct users were 
66% more likely to report ADHD symptoms that reached the clini-
cal cutoff (OR [95%CI] = 1.66 [1.27, 2.05], p < .01); however, they 
were not significantly more likely to report clinical symptoms of 
depression (OR [95%CI] = 1.10 [0.71, 1.49], p = .58) or generalized 
anxiety (OR [95%CI] = 1.13 [0.98, 1.28]; p = .43). Table 3 presents 
OR estimates for each mental health outcome and tobacco product 
use trajectory group contrast.
Sensitivity Analyses
A series of sensitivity analyses were conducted to assess if the results 
remained consistent when different subsets of the sample were 
excluded. Associations of polytobacco use trajectory groups with 
changes in substance use and mental health outcomes from baseline 
to the 24-month follow-up did not differ when: (1) students (N = 55, 
1.6%) whose reports were of questionable validity were removed 
(eg, reported use of a fictitious drug); (2) students (N = 377, 11.1%) 
who completed a follow-up survey by an alternate mode of sur-
vey administration other than in-class paper surveys (ie, telephone, 
internet, or mail) were removed; and (3) only the subsample of stu-
dents (N = 3082, 90.8%) who completed all five assessments were 
included (see supplemental materials). We did not find any meaning-
ful differences from the results using the total sample (N = 3393).
Discussion
To our knowledge, this is the first study to provide a parsimonious 
characterization of the broad variation in use and co-use of popu-
lar tobacco products across an important developmental period of 
risk (ie, mid-adolescence). Using an empirically derived modeling 
approach, this study identified three profiles with distinct trajectories 
that explained the heterogeneity in developmental patterns of use 
and poly use of tobacco products among adolescents: (1) Chronic 
polyproduct users; (2) Polyproduct users; and (3) Tobacco nonus-
ers. A key finding from this analysis is that prototypical patterns of 
use of tobacco products across mid-adolescence in this sample either 
involve the use of no products or some form of polytobacco product 
use. A single product user trajectory was not identified in the data. 
Hence, poly use is the norm and single product use is the excep-
tion, suggesting that a comprehensive approach to tobacco control 
in adolescents that addresses multiple products is warranted.
Consistent with results from national surveys,3 the majority of 
youth in this sample (67.5%) did not use any tobacco products, or 
had a negligible prevalence of past 6-month combustible cigarette, 
e-cigarette, and hookah use across mid-adolescence. Youth in the 
Chronic polyproduct and Polyproduct user groups displayed distinct 
patterns in their polytobacco use trajectories. Chronic polyproduct 
users (approximately 5% of the sample) had the highest prevalence 
of past 6-month combustible cigarette, e-cigarette, and hookah use 
at each assessment with escalating trajectories of combustible cig-
arette (38% to 68% across follow-up) and e-cigarette use (59% to 
83% across follow-up) during mid-adolescence. These youths may 
reflect those whose tobacco product consumption persists over time 
Table 3. Associations of Polytobacco Use Trajectory Groups With Substance Use and Mental Health Outcomes at 24-Month Follow-Up
Outcomes (W5)
Tobacco use trajectory groups
Chronic polyproduct users vs. 
Tobacco nonusers (ref)
Polyproduct users vs. Tobacco 
nonusers (ref)
Chronic polyproduct users vs. 
Polyproduct users (ref)
Past month substance use IRR 95% CI IRR 95% CI IRR 95% CI
 Alcohol use 5.632** 2.775, 8.489 3.524** 2.888, 4.160 1.902** 1.138, 2.667
 Marijuana use 7.425** 2.512, 12.338 5.344** 2.256, 8.431 2.159** 1.498,2.820
 Other illicit drug use 9.286** 5.424, 13.148 7.485** 3.292, 11.677 2.366** 1.598, 3.135
Mental health outcomes OR 95% CI OR 95% CI OR 95% CI
 Depression (CESD) 1.469** 1.146, 1.792 1.334** 1.080, 1.588 1.101 0.714, 1.488
 Anxiety (RCADS-GAD) 1.572** 1.133, 2.011 1.236* 1.043, 1.426 1.127 0.984, 1.277
 ADHD 2.597** 1.830, 3.364 1.394* 1.053, 1.735 1.663** 1.272, 2.054
N = 3393. IRR = Incidence Rate Ratio. OR = Odds Ratio. CI = Confidence Interval. Adjusted for parental education level, youth age, gender, ethnicity, other 
tobacco products use (eg, smokeless tobacco, cigars/cigarillos, dissolvable) in the past 6 months, and each outcome indicator at baseline. W5 = 24-month follow-
up. Mental health outcomes were coded by 0 = Scores below the clinical cutoff and 1 = Scores above the clinical cutoff. Past month substance use outcomes were 
coded as a count variable indicating number of days of substance use in the past month. *p < 0.05, **p < 0.01.
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without discontinuation for all products, which would presumably 
increase cumulative exposure to nicotine and potentially risk for 
dependence on one or more products.
Polyproduct users (27.1% of the sample) had moderate preva-
lence of past 6-month combustible cigarette, e-cigarette, and hookah 
use across the follow-up assessments, and displayed decreasing tra-
jectories of e-cigarette (33% to 21% across follow-up) and hookah 
use (27% to 17% across follow-up) but increasing prevalence of 
combustible cigarette use (8% to 20% across follow-up). An appre-
ciable proportion of adolescents initiate tobacco product use with 
e-cigarettes,34,35 and use of e-cigarettes or hookah among nonciga-
rette smoking youth is associated with combustible cigarette initi-
ation in bi-variate analyses of associations of use of these products 
with combustible cigarette use.22,36–39 The (nonchronic) polytobacco 
use trajectory identified in this study may be emblematic of such 
transitions and suggests temporary time limited use of hookah or 
e-cigarettes and with moderate risk of subsequent transition over to 
combustible cigarettes.
Extending extant cross-sectional data,16,17,19,40–42 the three polyto-
bacco use trajectory groups identified in this prospective study fol-
lowed a risk gradient for engaging in substance use behaviors and 
reporting clinical levels of mental health symptomology with: (1) 
Chronic polyproduct users displaying the highest risk; (2) Polyproduct 
experimenters displaying moderate risk; and (3) Tobacco nonusers 
with the lowest risk. Research examining polytobacco use prior to 
when e-cigarettes and hookah were available or popular had stud-
ied concurrent use of combustible cigarettes and smokeless tobacco 
products and found strong associations between polytobacco use and 
substance use, with polytobacco users more than 30 times as likely 
to subsequently use alcohol, marijuana, and cocaine.43 The results of 
the current study show that future substance use risk may also be 
elevated using diverse patterns of poly use of emerging tobacco prod-
ucts that are currently popular among adolescents.
Nicotine exposure during adolescence alters neurodevelopment 
and may increase vulnerability to substances of abuse45–47 as well 
as impacting mood and mental health.48 Given prior evidence that 
polytobacco use (vs. single product use) is positively associated with 
increased nicotine dependence,5,49 and polytobacco users have been 
shown to engage in more frequent smoking and vaping than single-
product users,42 increased exposure to nicotine may confer risk for 
substance use and mental health symptomology. However, it is also 
possible that risk factors not accounted for in the current analysis 
explain the observed association between polytobacco use trajecto-
ries and substance use and mental health. Polytobacco use may be 
a risk marker for subsequent substance use and mental health prob-
lems with chronic polytobacco product users representing high-risk 
adolescents,50 and less frequent polyproduct users being “lower-risk” 
teens with moderate levels of mental health and behavioral problems.
These findings could be used to inform interventions tailored to 
risky polyproduct user groups. For chronic polyproduct users, who 
present with the highest levels of subsequent and mental health prob-
lems, more intensive, multidimensional prevention programming (eg, 
mental health counseling in addition to substance use prevention/ces-
sation programs) may be fruitful for preventing a myriad of adverse 
risk outcomes. For the larger segment of youth who experiment e-cig-
arettes and hookah primarily at the outset of high school (similar 
to the polyproduct users in this study), escalating combustible ciga-
rette use risk may be a concern that warrants additional intervention 
focus as well as a considering programming to address the moderate 
increase in risk of substance use and mental health problems. Future 
research should examine potential mechanisms of protective factors 
for developing targeted interventions based on multidimensional 
characterizations of polytobacco product use. Also, consistent with 
prior research indicating that use of e-cigarettes and multiple tobacco 
products is prevalent in Hispanic youth,4 we found that Hispanic 
youth constitute more than 50% of the Chronic polyproduct user 
and Polyproduct user groups. This finding reinforces the need for 
research focusing on tobacco-related health disparities among ethnic 
minority groups, particularly during adolescence.
Strengths of this study include the large and demographically 
diverse sample, repeated follow-up assessment strategy over a 2-year 
period, low attrition rate, modeling of complex patterns of comorbid 
tobacco trajectories, and adjustment for baseline outcomes as well as 
potential confounders. To minimize participant burden on students 
and schools, this study only included self-report measures, which 
can result in measurement limitations. Although the past 6-month 
use of each tobacco product was reported only as a binary outcome 
(yes/no), we also examined past 30-day frequency of product use 
where data was available—and these responses closely matched the 
past 6-month cigarette use prevalence (see Supplementary Table S2). 
Future research should utilize past 30-day frequency of tobacco 
product use in GMM models to capture greater variability in more 
frequent patterns of use. Additionally, e-cigarettes and hookah may 
contain variable amounts of nicotine,46 and adolescents may not be 
aware if the e-cigarettes or hookah they are using contain nicotine;51 
hence, the extent to which these findings reflect targets for regulatory 
policy targeting products with nicotine is not known.
These limitations notwithstanding, the present study could serve as 
a methodological and conceptual template for future work investigat-
ing developmental patterns of polytobacco use among youth at a time 
of increasing diversity of tobacco products. More broadly, research 
like the current study that increases understanding of diverse develop-
mental patterns of polytobacco use and their relations with subsequent 
health risks can inform researchers and policy makers regarding the 
prevalence and potential consequences of concurrent use of multiple 
tobacco products. If the associations demonstrated here were eventu-
ally determined to be causal, these results suggest that policy and pre-
vention reducing the appeal of and access to various tobacco products 
may reduce the substance use and mental health burden in current and 
future generations of youth. In an increasingly diverse market place 
in which tobacco products and their use patterns are becoming more 
complex, it will be important to continue characterizing patterns of 
use and co-use of multiple tobacco products in ongoing surveillance 
of adolescents. As the marketplace and policy landscape continues to 
evolve, such evidence will be necessary to determine whether, amongst 
youth, polyproduct use remains the norm and increases risk of adverse 
substance use and mental health outcomes.
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